Repros Therapeutics Inc. Enters Oversold Territory - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

Repros Therapeutics Inc. 's ( RPRX ) share price has entered into oversold territory with a stochastic value of 18.6275. The Zacks Consensus Estimate on the company's loss for year ending December 2012 decreased by 5 cents over the past two months to a loss of 70 cents per share. Repros Therapeutics Inc. is a Zacks #2 Rank ("Buy") company.


REPROS THERAPEU (RPRX): Free Stock Analysis Report
To read this article on click here.
Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: RPRX

More from


Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by